PHARMAID Pharma Aids Limited
Pharmaceuticals & Chemicals
Tk 505.6 as of 2026-11-12 14:05:02
Rank 97 of all scored
Data completeness 100%
Data completeness 100%
Score breakdown
Consistency 70
Profitability 59
Solvency 100
Valuation 31
Weights: consistency 30%, profitability 30%, solvency 20%, valuation 20%; then risk flags add or subtract points. Full method
Why this score
Strengths
- Consistency Paid a dividend every year (5/5)
- Solvency Practically debt-free (loan risk cannot hurt it)
Concerns
- Consistency Net loss in 1 of the last 5 years
- Valuation Trades at 3.1x book value (NAV Tk 163.31, price Tk 505.6)
- Valuation Price is 57% above the Graham fair value (Tk 321.0)
Notes
- Consistency EPS rose in 2 of 4 years (mixed)
- Profitability Average ROE 11.35% (moderate)
- Valuation P/E 18.02 is fair
Risk flags
- Small cap (< Tk 200 cr): most exposed to manipulation and volatility
Valuation
P/E
P/E audited
P/E current
P/B
NAV per share
EPS (last audited year)
Graham fair value
Margin of safety
52-week range
11.7% above the low, 25.7% below the high. Near the low is only interesting if profit is intact (see concerns above) and the fall has a temporary cause.
Quality and growth
ROE
ROE avg
ROE min
Profit CAGR
Profit YoY
Net profit
EPS up
Loss years (last ~5)
Dividends and safety
Div years
Dividend yield
Payout
Cash div
D/E
Loans/MCap
Size, liquidity and ownership
MCap
Free float
Daily turnover
Sponsor %
Inst. %
Public %
Foreign %
Shareholding
- Sponsor/director 19.4%
- Institution 19.7%
- Public 60.9%
Audited history
| Year | EPS (Tk) | NAV/share | Net profit (cr) | Cash div % | Bonus % |
|---|---|---|---|---|---|
| 2021 | 16.11 | 93.26 | 5 | 50 | 0 |
| 2022 | 11.14 | 98.83 | 3 | 50 | 0 |
| 2023 | -2.05 | 91.28 | -1 | 10 | 0 |
| 2024 | 19.61 | 109.89 | 6 | 25 | 0 |
| 2025 | 20.45 | 138.58 | 6 | 30 | 0 |
Fiscal year ends June. EPS, NAV and profit are as audited by the company and published by DSE. Financials last fetched: 14/11/2026.
Shariah screen (partial)
Business screen and the debt ratio (loans / market cap 0.6%, limit 33%) are automated. Interest income (under 5% of revenue) and cash/investment ratios must be checked in the annual report.
Educational, not investment advice. Verify on DSE and StockNow before making any decision.